Fresenius Medical Care AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE0005785802
EUR
38.54
-44.79 (-53.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

747.11 k

Shareholding (Dec 2025)

FII

0.09%

Held by 3 FIIs

DII

99.91%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt company with Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 1.58% and Operating profit at -7.20% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
  • OPERATING PROFIT TO INTEREST (Q) Lowest at 7.01 times
  • CASH AND CASH EQUIVALENTS(HY) Lowest at EUR 1,148.00 MM
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.87 times
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 11,308 Million ()

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

3.74%

stock-summary
Debt Equity

0.54

stock-summary
Return on Equity

9.89%

stock-summary
Price to Book

0.85

Revenue and Profits:
Net Sales:
5,070 Million
(Quarterly Results - Dec 2025)
Net Profit:
403 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-57.04%
0%
-57.04%
6 Months
-43.43%
0%
-43.43%
1 Year
-47.6%
0%
-47.6%
2 Years
-51.18%
0%
-51.18%
3 Years
-60.01%
0%
-60.01%
4 Years
-53.0%
0%
-53.0%
5 Years
-57.24%
0%
-57.24%

Fresenius Medical Care AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.91%
EBIT Growth (5y)
-2.96%
EBIT to Interest (avg)
4.39
Debt to EBITDA (avg)
2.10
Net Debt to Equity (avg)
0.44
Sales to Capital Employed (avg)
0.82
Tax Ratio
33.92%
Dividend Payout Ratio
44.35%
Pledged Shares
0
Institutional Holding
0.09%
ROCE (avg)
8.54%
ROE (avg)
8.48%

Valuation key factors

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
0.88
EV to EBIT
9.51
EV to EBITDA
5.32
EV to Capital Employed
0.92
EV to Sales
0.91
PEG Ratio
0.21
Dividend Yield
3.62%
ROCE (Latest)
9.63%
ROE (Latest)
9.89%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 3 Foreign Institutions (0.09%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 3.79% vs 1.95% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 23.13% vs 20.20% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,070.00",
          "val2": "4,884.90",
          "chgp": "3.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "951.00",
          "val2": "856.30",
          "chgp": "11.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "99.00",
          "val2": "93.10",
          "chgp": "6.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-44.00",
          "val2": "-11.60",
          "chgp": "-279.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "403.00",
          "val2": "327.30",
          "chgp": "23.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "114.00%",
          "val2": "102.00%",
          "chgp": "1.20%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 1.55% vs -0.60% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 60.79% vs 1.15% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "19,636.90",
          "val2": "19,337.70",
          "chgp": "1.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,347.90",
          "val2": "3,179.60",
          "chgp": "5.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "354.30",
          "val2": "397.10",
          "chgp": "-10.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-34.40",
          "val2": "-487.20",
          "chgp": "92.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,191.30",
          "val2": "740.90",
          "chgp": "60.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "96.00%",
          "val2": "85.00%",
          "chgp": "1.10%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
5,070.00
4,884.90
3.79%
Operating Profit (PBDIT) excl Other Income
951.00
856.30
11.06%
Interest
99.00
93.10
6.34%
Exceptional Items
-44.00
-11.60
-279.31%
Consolidate Net Profit
403.00
327.30
23.13%
Operating Profit Margin (Excl OI)
114.00%
102.00%
1.20%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 3.79% vs 1.95% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 23.13% vs 20.20% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
19,636.90
19,337.70
1.55%
Operating Profit (PBDIT) excl Other Income
3,347.90
3,179.60
5.29%
Interest
354.30
397.10
-10.78%
Exceptional Items
-34.40
-487.20
92.94%
Consolidate Net Profit
1,191.30
740.90
60.79%
Operating Profit Margin (Excl OI)
96.00%
85.00%
1.10%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 1.55% vs -0.60% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 60.79% vs 1.15% in Dec 2024

stock-summaryCompany CV
About Fresenius Medical Care AG stock-summary
stock-summary
Fresenius Medical Care AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available